Cohort study on ischemic stroke patients
a Prospective, Multicenter Cohort Study of Ischemic Cerebrovascular Disease
This study is trying to gather information from a large group of people who have had an ischemic stroke to see if certain biological markers can help predict risks and outcomes for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Hunan) |
| Trial ID | NCT05922540 on ClinicalTrials.gov |
What this trial studies
This study aims to create a large-scale, multicenter cohort of patients diagnosed with ischemic stroke. It involves the collection of various biological samples, including blood, feces, and urine, to identify potential biomarkers linked to ischemic stroke. The study will integrate demographic data, clinical indicators, imaging parameters, and biomarker information to develop models for risk assessment, early warning, and prognosis prediction. Additionally, it seeks to identify key genes and explore relevant signaling pathways associated with ischemic stroke.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been clinically diagnosed with ischemic stroke.
Not a fit: Patients with moderate to severe mental disorders, concurrent malignant tumors, or those unable to cooperate with study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and treatment strategies for patients suffering from ischemic stroke.
How similar studies have performed: Other studies have shown promise in identifying biomarkers for ischemic stroke, suggesting that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical diagnosis of ischemic stroke. 2. Age ≥ 18 years. 3. Signed informed consent form. Exclusion Criteria: 1. Patients with moderate to severe mental disorders or dementia who cannot cooperate to complete the informed consent and follow-up procedures. 2. Patients with neurological functional impairment caused by conditions such as migraine aura, epilepsy, or other non-ischemic strokes. 3. Agitated patients who cannot cooperate with imaging examinations. 4. Pregnant or lactating patients, as well as those planning to become pregnant within 90 days. 5. Patients with concurrent malignant tumors or severe systemic diseases with an expected survival period of less than 90 days. 6. Patients who have participated in other clinical studies within 30 days prior to enrollment or are currently participating in other interventional clinical studies.
Where this trial is running
Hunan
- Xiangya Hospital, Central South University — Hunan, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.